chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Slight redness to lower forearm, sore throat, feverish, fatigue, ear pain
DTaP (Daptacel) given in left arm on 02/05/2004. 3" x 6" red, swollen upper arm. Mild fever- 100 degrees. Cool compress Atarine.
Developed rash; Clinically confirmed that it was shingles by urgent care; This case was reported by a other health professional via sales rep and described the occurrence of rash in a 60-year-old female patient who received Herpes zoster (Shingrix) (batch number AG7M9, expiry date unknown) for prophylaxis.   On 16th October 2020, the patient received the 1st dose of Shingrix. In October 2020, 4 days after receiving Shingrix, the patient experienced shingles. On 20th October 2020, the patient experienced rash. On an unknown date, the outcome of the rash and shingles were unknown.   It was unknown if the reporter considered the rash and shingles to be related to Shingrix.  Additional details were provided as follows: After receiving 1st dose of Shingrix, the patient experienced rash and shingles. The reporter consent to follow up.
The client was inadvertently given the Moderna COVID vaccine when he should have received Pfizer. The Moderna vaccine has not yet been authorized for the clients age group. The client was advised to wait 30 minutes for observation after receiving the vaccination in which time he showed no adverse reactions. The clients mother was told she would be contacted with instructions for the clients second dose after CDC guidelines could be consulted regarding which vaccine he should receive next.
9 days post vax, the pt developed a fever of 102 which continued over 7/29/00. The pt slept allot and then the fever resolved on 7/30/00. The following day, the pt developed a patch of bumps over the belly, back and hands, feet, and legs.
On the afternoon of the immunization, patient started to have a severe headache and sore arm. The next morning, the muscle where the immunization was given was tender to touch, warm, and red.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 62-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 08Oct2022 as dose 5 (booster), single (Lot number: GH9693) at the age of 62 years for COVID-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Insomnia" (unspecified if ongoing); "Allergic rhinitis" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Cephalexin, reaction(s): "Known allergies: Cephalexin"; Celebrex, reaction(s): "Known allergies: Celebrex"; Sulfa, reaction(s): "Known allergies: Sulfa". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (24Dec2022) Negative, notes: On day 11 I was negative on a lateral flow home test. On day 12 I tested again prior to an event and was positive; (25Dec2022) Positive, notes: On day 11 I was negative on a lateral flow home test. On day 12 I tested again prior to an event and was positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.; Sender's Comments: The vaccine efficacy varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect vaccine BNT162B2, BNT162B2 OMI BA.4-5  to the drug ineffective (LOE) and Covid -19 cannot be ruled out.
Devel head cold 24 hrs p/vax devel dull h/a @ same time; excessive nasal discharge x 3 days; no fever; fine today 12NOV91;
I noticed I was unable to focus and becoming easily confused and disoriented on Wednesday, March 10, 2021. I found it difficult to navigate very familiar things like excel and navigating email communications. On Saturday, March 13, 2021, I was cooking with a couple of family members and I became confused and could not remember that I had something in the oven, what I was supposed to be cooking although I was whisking eggs at the time, who wanted what, etc. I became disoriented easily and almost burned my sister with hot grease, almost set the kitchen on fire when I set a dish towel on a still lit burner on the stove. Later on when playing scrabble, my favorite game, I had trouble adding up the points, I continuously counted over and over and then promptly forgot. I had trouble remembering who just went and constant wrote the scores under the wrong name. Could not remember the order of players and it was only three of us.
Severe pain - whole body - muscles stiff - jaw muscles sore sore throat - needed assistance dressing - getting out of bed - etc. Used wheel chair and cane - legs weak- muscle spasms. Various places each day = shoulders, neck- trapezius muscles all stiff and aching - shot given 2-3-09 - Severe symptoms appeared 2-5-09 pain meds. 4/6/09 Received PCP medical records of FINAL DX: none provided Records reveal patient experienced usual state of health when seen 2/3 for routine PE & Td updated. Last Td 5/99.  T/C to clinic 2/5/09 w/increase in joint pain over past several weeks.  Requested referral to rheumatology. Follow-up: Contractions, cramps - sore throat - all over body pain - weakness - sore joint muscles -needed assistance bathing- dressing -getting out of bed - upper arms wasted away- weight loss - stiffness - pain and muscle problems moved place to place day by day. At the last visit with my civilian doctor PCP we discussed the vaccine amount given to me - He handed me a syringe and asked me to show him how much was in the syringe just before I got the shot- I showed him what I saw and he explained that the normal adult dose age is .5cc and in his opinion the nurse gave me 5 cc which would have been 10 times the normal dosage which is a massive over dose. Before the nurse gave me the shot during the regular visit that day she asked if I was taking any new meds. I told her I had just finished 2 MEDROL packs. I now am also on LYRICA - 75mg in A.M. and 150mg P.M. and Doxycycline 100mg. twice daily.
Both vaccines given in the same arm resulting in significant pain and swelling and a visit to the ED.  Seen 4 days after the shots and was found to have cellulitis in the arm and was treated with Bactrim 400mg,
I have seen the patient for many years and has never had a heart murmur or any heart concerns.   I had seen the patient about one month after the vaccination and I did not find any problems.   At the next visit on 6/9/21 I found that the patient had a cardiac murmur.  The patient also had shortness of breath.   I felt the patient most likely had bronchitis and pt was treated and resolved however I also followed up with the murmur two weeks later and the murmur was still present.   I sent the patient to cardiology for further eval.
Patient did not report his age to the nurse until after he received the vaccine. Patient is 17 years old. Patient was monitored for the full 15 minutes and discharged without any symptoms.
Child awoke from nap and fever 102F, swelling and redness on right deltoid. Child seen in health dept at 16:30 PM. Mom reports fever broke shortly after getting up from nap. Redness noted on right deltoid 5 cm in diameter. No swelling. Area warm and tender.
tested positive for COVID-19; he wasn't breathing right; loss of sense of taste; loss of sense of smell; A spontaneous report was received from a consumer concerning a 70-year-old male patient, tested positive for COVID-19, had loss of sense of smell and taste, and was hospitalized because he was not breathing right/COVID-19.   The patient's medical history included blood pressure, cholesterol and unspecified prostate. Concomitant medications included unknown medication for his blood pressure, unknown cholesterol medication, and unknown prostate medication.    On 30 Jan 2021, prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Lot number: 012L20A) for prophylaxis of COVID-19 infection.  On 02 Feb 2021, the patient had loss of sense of smell and taste. On 05 Feb 2021, he tested positive for COVID-19 and was hospitalized because he wasn't breathing right. He returned home on 08 Feb 2021.   Treatment for the event included vitamins, dexamethasone, pantoprazole, steroids, and remdesivir.   Action taken with mRNA-1273 in response to the event was not provided.   The outcome for the event wasn't breathing right was resolve don 08 Feb 2021.   The outcome for the events tested positive for COVID-19, had loss of sense of smell and taste was considered as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Treatment of COVID-19; Treatment of COVID-19; vaccine dose number=3/Moderna/vaccine dose number=4/Moderna; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 16Feb2021 as dose 1, single (Lot number: EL9266), in right arm and on 09Mar2021 as dose 2, single (Lot number: EN6206) at the age of 40 years, in right arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 28Oct2021 as dose 3 (booster), single (Lot number: 062E21A), in right arm, on 12Jun2022 as dose 4 (booster), single (Lot number: 038A22A), in right arm and on 21Sep2022 as dose 5 (booster), single (Lot number: AS7162B), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: FIORICET. Past drug history included: Codeine, reaction(s): "Known allergies: codeine"; Aspirin, reaction(s): "Known allergies: aspirin"; Vancomycin, reaction(s): "Known allergies: vancomycin". The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 28Oct2021, outcome "unknown", described as "vaccine dose number=3/Moderna/vaccine dose number=4/Moderna"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19.
stomach pain, diarrhea, immediately followed the vaccine 2 days after the vaccine & lasted one week
56 year old female presents with complaint of tingling and numbness that she noticed to her lower left jaw.  It occurred yesterday around 3 PM after she received her Covid vaccination.  She states that then started to move up to her left cheek but has now gone back down just to the lower left jaw.  It is in a specific region of that area.  She states also that she is having a fever today and generalized body aches that are moderate in nature.  She also notes some urinary frequency without dysuria or hematuria.  Patient took Tylenol this morning around 6 AM.  She initially tried to swallow the pill and felt like she was going to choke on it and spit the pill up.  She then sat down for a few minutes and was then able to take the pill.  She denies any actual stridor or wheezing.  No focal weakness or numbness of one arm or leg.  No change in speech. Differential diagnoses include but are not limited to: CVA, TIA, anxiety reaction, paresthesia, metabolic process, bleed, vaccine reaction.  56-year-old female with paresthesia to the left chin.  Otherwise normal neurologic examination.  The TPA window given symptoms started yesterday.  I will get a head CT but I do not feel the patient needs an MRI.  Given the fact the patient does have autoimmune disorder, blood cultures and lactic acid obtained.  I suspect that her fever is in response to her Covid vaccine yesterday.  Covid test negative.  Urinalysis no evidence of UTI.  Chest x-ray is clear.  Head CT negative.  On reevaluation after Motrin patient feels much improved.  At this time I think she is stable for discharge to home.  I do not think this is Bell's I am finding no facial weakness on my examination.  Follow-up and return precautions discussed patient understood
SOB, bad taste in mouth, (R) arm pain pt was given epinephrine 0.2 cc 1:1,000.
Patient had several hospital visits after her second Pfizer dose, for symptoms including pneumonia. Her primary caretaker said that her rapid health decline happened immediately after this second dose. Finally she succumbed to death on April 7th, six weeks after her shot. It was reported that she died of sepsis.
9/22 Ultrasound showed no fetal heartbeat.  (On 09/17/2010 there was a confirmed pregnancy, and ultrasound with fetal heartbeat clearly visable.)  D&C was done.
HIV labs which were all negative/ was given a false negative disposition; HIV labs which were all negative/ was given a false negative disposition; This is a spontaneous report from a contactable other health professional (patient). A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on 22Dec2020 at 08:30 (first dose, lot number: EK5730) in the arm left and on 12Jan2021 (second dose, lot number: EL3248) in the arm right; both via  an unspecified route of administration as single dose for COVID-19 immunization. Medical history included false positive HIV. No allergies to medications, food, or other products. Concomitant medications included cetirizine; sertraline; and ethinylestradiol, norgestimate (TRI-SPRINTEC). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not pregnant at the time of vaccination. On 06Jan2021 at 08:00, patient had a reactive screening for HIV. The Infectious Disease Specialist has ordered HIV labs which were all negative. At this point, patient was given a false negative disposition. The event resulted in doctor or other healthcare professional office/clinic visit, disability or permanent damage (as reported). The patient received the second dose of vaccine on 12Jan2021. Then on 06Mar2021, patient went for a second HIV testing site and tested negative. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was unknown.; Sender's Comments: Based on limited information, there is not a reasonable possibility of a causal relationship between the reported events and suspect drug BNT162B2. The case will be reassessed  on follow up information.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events.  Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
sx of itchiness & swelling around the mouth began 29MAR92 & malaise & h/a; pt given DPH x 2 days swelling cont external mouth, face & around ears-dec 3APR but still present; returned to work 3APR still has itchiness;
Vaccination on Mon 4/5, that night general aches arms & legs, next day injection site very tender & red. On exam 4/8, 3 cm area of vesicles L arm @ injection site with 6 cm surround by erythema.
7-1-15 TC to pt to give lab results-he stated he had cellulitis and got abx from ER-arm is better now-pt declines to report to VAERS-record requested from ER. 6-20-15 pt. presented to ER c/o site red, swollen and painful c/o feels run down. T=98.3 degrees F, BP 127/70 P103 R 20 wt 242.51 lbs. Dx-(L) arm cellulitis given abx (per ER note rec'd 7-6-15).
Fever, headache, swollen cervical lymph nodes bilaterally, swollen and erythema at injection site, muscle pain, joint pain, sore throat, nausea and vomiting. (Negative home Covid test.). Nausea and vomiting that required an ER visit for antiemetics and intravenous fluid rehydration.   Unable to work as RN for 4 days
Pt explained he had intestinal cramps starting 2 days after injection, followed by shivers for 2 days, followed by myalgias for 2 days.
Severe headache, body aches, fatigue, hot flashes, and arm pain lasting greater than 72 hours post vaccine. Given ibuprofen which didn?t help much.
pt received Pfizer booster on 09/08/2022 pt tolerated well was monitored for 15mins no adverse reaction
This case was reported by a pharmacist via call center representative and described the occurrence of shivering in a patient who received SHINGRIX. In March 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In March 2018, 1 day after receiving SHINGRIX, the patient experienced shivering. In March 2018, the outcome of the shivering was recovered/resolved. The reporter considered the shivering to be almost certainly related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The site of injection was either the right or left arm, the reporter could not remember. The healthcare professional stated a patient (could not remember which patient so did not have details) reported shivering. It resolved quickly and no action was taken.
On 4/27/2021 in the afternoon, I felt not bad in the morning so I went to animal room to help lab mates? experiment. However, I felt hard to breath and dizziness I. That room (the AC in that room probably also had some problem and the circulation system as well) then, I went outside to breath fresh air and came back again to do the experiment. Felt better after 4:00 pm. At night, I tested my temperature and saw 37.7 C. The next day, I felt dizziness all day. Then, Friday of this week, I went to the center and tested COVID, it showed negative.
arm pain at injection site; headache; slight itchy rash on hand of injection arm; This is a spontaneous report from a contactable consumer (patient) via Covid-19 Adverse Event Self-Reporting Solution (COVAES).  A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in Arm Left on 23Feb2021 09:30 (lot number: EL3247; expiry date: unknown) at the age of 35-years-old, as dose 1, single, for Covid-19 immunization. Medical history included hypertension and obesity. Concomitant medications included metoprolol, ethinylestradiol, norgestimate (ORTHO TRI-CYCLEN LO), and vitamins NOS both taken for unspecified indications, start and stop dates were not reported. The patient previously received cefaclor (CECLOR) and experienced allergies. The vaccine was administered in a workplace clinic. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The patient has not been tested for COVID-19 since vaccination. On 24Feb2021 at 19:00, the patient experienced arm pain at injection site, headache and slight itchy rash on hand of injection arm. The patient did not receive treatment for the events. Outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected.
Patient was in office to receive his first dose of the Pfizer vaccine. When staff member drew and administered she mistakenly pulled the entire reconstitution value and administered into the left deltoid. I have contacted patient and he reports a sore arm. I have advised he follow current CDC guidelines and take Tylenol and/or use an ice pack for the tenderness in his arm.
A report was received from a health care professional on 12/3/03 concerning eight vaccinees of unspecified sex and under 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date, eight vaccinees under 4 years of age inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality. Update 1/20/04: Follow up information received from a health care professional indicated that a 2 year old male vaccinee inadvertently received Fluvirin on 11/24/03. No follow up pending.
The pt developed an ataxic gait on 3/1/2000 after receiving vaccine on 2/25/2000.
Severe constipation followed by severe diarrhea 3-5 days after the constipation.  Shortness of breath and chest pain when exercising or walking up steps. Worsening of arthritis.  Severe fatigue
No adverse effects, but patient was vaccinated on 9/29/23 and it was noticed on 10/9/23 that a vial of diluent was missing from the Shingrix box, after investigation it was found this patient only received the diluent instead of the diluent mixed with powder vaccine for Shingrix.  Nursing giving the shot was unfamiliar with the product and was unaware it needed a powder to be reconstituted. So patient was not actually vaccinated for Shingles correctly.    Patient will be contacted to return to clinic to get fully vaccinated for Shingles.
There was blistering around the injection site that continued down my arm for days Still present as I report this
Fever began around 9:30 pm and continued off and on through around 11pm the next day.  Pain in fingers, toes and back. Headache unlike a normal headache or migraine . There was a dull constant pain everywhere, but also shooting pains on the sides of my head. A great deal of fatigue and general achiness.
Sudden onset stuttering. Has never stuttered before, it progressively got worse over the next few days. On Friday am, I consulted his pedi and she said take him to the emergency room. They did no diagnostics and sent us home. It got very bad over the next week and then all of the sudden got a lot better. He is still having stuttering difficulties to this day but has gotten better since the first week.
After shot was administered into my left arm, I felt a burning sensation and I started having problems walking on my right leg. Two days later, I had a severe headache followed by fever, chills, breathlessness, weakness and disorientation.
Fever 104 degrees F & 105 degreex F onset 3 days after shots (HEP A #2 & Flu shot). On 11/15/10 diagnosed with pharyngitis and treated with Rx AUGMENTIN.
Expired vaccine Hep B was given to pt. All but one vaccine in the bag of Engerix Hep B expired in 2024 one given to pt expired 12/2022. Pt and provider was informed. Patient later deferred to health department to receive proper vaccinations, unknown follow up.
PsO reappear on her scalp; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced pso reappear on her scalp on an unspecified date. Outcome of the event was unknown.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Local erythematous plaque overlying injection site, 8cm diameter, warm, firm, pruritic, painful.
Client had H1N1 mist.  One hour after vaccination, upper lip under nose became red and swollen.  Mom did not treat with anything.  Swelling decreased but slightly red next morning.  Patient did not complain of pain.  Reported by mom.